Sycamore Partners reportedly working on financing to acquire Walgreens

Sycamore Partners is reportedly working with Morgan Stanley and UBS on a $10 billion financing package for a potential acquisition of Walgreens, per a MSN report that cited a posting on X from Octus, formerly known as Reorg. 

The report said that according to the post, a potential buyout would include terms loans, a bridge loan and asset-based lending.  

[Read more: Apollo, Sycamore, Brigade reportedly vying for Family Dollar]

The news about Sycamore in talks about financing the potential deal comes on the heels of CNBC's David Faber's report last Tuesday that Sycamore's takeover talks were still alive.

[Read more: Sycamore Partners' deal with Walgreens reportedly still possible]

A spokesperson at Sycamore contacted by Drug Store News said the company has no comment.

A Walgreens spokesperson contacted by DSN said, "We don’t comment on rumors or speculation about our business."